Monoclonal Antibodies for MS Treatments MStranslate October 20, 2016 Research, Understanding Science By Brett Drummond What’s in a name? I was recently asked a question: “Why do all of the new MS drugs end in mab? Does that mean something?”. The answer is yes and it’s probably worth...
Rates of MS Progression: Dr Tomas Kalincik (MSBase) MStranslate October 11, 2016 Q&A, Research Upon his return from ECTRIMS 2016, Dr Tomas Kalincik from the Melbourne Brain Centre at Royal Melbourne Hospital spoke to MStranslate about recently published research by MSBase investigators. Their...
Clinically Stable MS & Magnetic Resonance Imaging MStranslate October 3, 2016 Neuroimaging, Research What is clinically stable multiple sclerosis? As most of you might be aware, the most common form of multiple sclerosis is relapsing-remitting MS (RRMS). In RRMS, people may go through periods of attacks...
ECTRIMS 2016: An Overview of Key Outcomes MStranslate September 22, 2016 Conferences, ECTRIMS, Research, Social Media Each year, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) holds the largest MS research meeting in the world. In 2016, this event was held in London, England, between...
High-dose Biotin Clinical Trial Results MStranslate September 13, 2016 Biotin, Clinical Trials, Research, Treatments 1 Comment Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The background Whilst many treatments are now available for...
New Studies Question Gene Mutation Link to MS MStranslate September 12, 2016 Genetics, Research The results of an MS genetic study published in Neuron earlier this year are now being called into question. You may remember that MStranslate did a summary on this article and interviewed the lead researcher,...
The Misdiagnosis of Multiple Sclerosis: A Study MStranslate September 1, 2016 Research A study has provided evidence to something that has been discussed anecdotally for quite some time - a diagnosis of multiple sclerosis (MS) is difficult to make and it's sometimes made incorrectly. The study...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to be beneficial for many people with MS and works by...
EAE Study Shows Multiple Benefits of Exercise MStranslate August 1, 2016 Exercise, Lifestyle, Research The background It is known that problems with the blood-brain barrier (BBB) and the immune system contribute to the damage seen in multiple sclerosis (MS). These problems are often worsened by oxidative...
Lifestyle Modifications to Manage MS Symptoms MStranslate July 19, 2016 Collaboration, Diet, Lifestyle, Research 2 Comments During July 2016, we have had the privilege of collaborating with Professor George Jelinek and the Neuroepidemiology Unit based at The University of Melbourne. In the first feature filmed with the group,...
